Coinbase Global ( COIN ) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Coinbase Global (COIN) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Kinsale Capital Group ( KNSL ) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Kinsale Capital Group (KNSL) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Here's What Key Metrics Tell Us About Twilio ( TWLO ) Q4 Earnings
While the top- and bottom-line numbers for Twilio (TWLO) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Fortis Inc. Announces Second Quarter Dividends - 2025
This news release constitutes a "Designated News Release" incorporated by reference in the prospectus supplement dated December 9, 2024 to Fortis' short form base shelf prospectus dated December 9, 2024.
Fortis Inc. Announces Second Quarter Dividends - 2025 - Fortis ( NYSE:FTS )
This news release constitutes a "Designated News Release" incorporated by reference in the prospectus supplement dated December 9, 2024 to Fortis' short form base shelf prospectus dated December 9, 2024.
Ryoncil® FDA Approval and Market Launch Highlighted at Tandem Transplantation Meetings
NEW YORK, Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Mesoblast Limited ( Nasdaq:MESO. ASX:MSB ) , a global leader in allogeneic cellular medicines for inflammatory diseases, today announced that its recently approved product Ryoncil® ( remestemcel-L ) is being highlighted at the 2025 Transplantation & ...
Ryoncil® FDA Approval and Market Launch Highlighted at Tandem Transplantation Meetings - Mesoblast ( NASDAQ:MESO )
NEW YORK, Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Mesoblast Limited MESOMSB ) , a global leader in allogeneic cellular medicines for inflammatory diseases, today announced that its recently approved product Ryoncil® ( remestemcel-L ) is being highlighted at the 2025 Transplantation & Cellular ...
How to Buy Gold Right Now
Tracey Ryniec and Neena Mishra, Zacks Director of ETF Research, discuss the hot gold rally, gold stocks and ETFs.
Applied Materials Hits Its Q1 Guidance
Applied Materials reported record revenue in its fiscal 2025 first quarter, but a significant overseas tax charge impacted its bottom line.
FEMSA Schedules Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results
MONTERREY, Mexico, Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Fomento Económico Mexicano, S.A.B. de C.V. ( "FEMSA" or the "Company" ) ( NYSE: FMX. BMV: FEMSAUBD, FEMSAUB ) is pleased to invite you to participate in its Fourth Quarter and Full Year 2024 Conference Call that will be held on: ...




